Cargando…

Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study

INTRODUCTION: The current extent of migration to the European continent is associated with exceptional humanitarian challenges. In 2015, Western Europe faced an enormous immigration of refugees with largely unknown protection status against communicable diseases. To adapt vaccination strategies, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jablonka, Alexandra, Happle, Christine, Wetzke, Martin, Dopfer, Christian, Merkesdal, Sonja, Schmidt, Reinhold E., Behrens, Georg M. N., Solbach, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700889/
https://www.ncbi.nlm.nih.gov/pubmed/28875465
http://dx.doi.org/10.1007/s40121-017-0169-7
_version_ 1783281211541553152
author Jablonka, Alexandra
Happle, Christine
Wetzke, Martin
Dopfer, Christian
Merkesdal, Sonja
Schmidt, Reinhold E.
Behrens, Georg M. N.
Solbach, Philipp
author_facet Jablonka, Alexandra
Happle, Christine
Wetzke, Martin
Dopfer, Christian
Merkesdal, Sonja
Schmidt, Reinhold E.
Behrens, Georg M. N.
Solbach, Philipp
author_sort Jablonka, Alexandra
collection PubMed
description INTRODUCTION: The current extent of migration to the European continent is associated with exceptional humanitarian challenges. In 2015, Western Europe faced an enormous immigration of refugees with largely unknown protection status against communicable diseases. To adapt vaccination strategies, we aimed at assessing seroprevalences against three of the most relevant vaccine preventable diseases (VPD) in a large representative cohort. METHODS: IgG seroprevalences for rubella, varicella (n = 554) and measles (n = 552) were analyzed in inhabitants of a Northern German refugee camp in the summer of 2015. RESULTS: Of the refugees, 77.9% were male (mean age 27.4 years for male and 26.8 years for female migrants). Most refugees came from the Eastern Mediterranean region (83.4%), followed by immigrants from Eastern Europe (7.4%), Africa (4.6%), or other regions (4.5%). The vast majority of migrants were protected against the three VPD: overall IgG seropositivity was 88.5% for measles, 77.9% for rubella and 95.9% for varicella. However, seroprevalences showed age- and origin-dependent differences. Varicella immunity, for example, was lowest in the youngest age group of both genders (10.1% of male/4.5% of female seronegative refugees <18 years vs. 100% seropositivity in men and women >49 years of age), and Sudanese migrants displayed particularly low rates of protection against varicella. CONCLUSION: In accordance with previous studies, our analyses show an overall satisfactory seropositivity against measles, rubella, and varicella in refugees entering Europe during the current exodus. However, this rate is not sufficient for preventing transmission. For example, the rate of 12.9–17.9% female refugees at reproductive age unprotected against measles and the low protection levels against varicella in minors observed in our cohort emphasizes the need for stringent vaccination strategies in refugees coming to Europe during the current crisis.
format Online
Article
Text
id pubmed-5700889
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-57008892017-12-05 Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study Jablonka, Alexandra Happle, Christine Wetzke, Martin Dopfer, Christian Merkesdal, Sonja Schmidt, Reinhold E. Behrens, Georg M. N. Solbach, Philipp Infect Dis Ther Original Research INTRODUCTION: The current extent of migration to the European continent is associated with exceptional humanitarian challenges. In 2015, Western Europe faced an enormous immigration of refugees with largely unknown protection status against communicable diseases. To adapt vaccination strategies, we aimed at assessing seroprevalences against three of the most relevant vaccine preventable diseases (VPD) in a large representative cohort. METHODS: IgG seroprevalences for rubella, varicella (n = 554) and measles (n = 552) were analyzed in inhabitants of a Northern German refugee camp in the summer of 2015. RESULTS: Of the refugees, 77.9% were male (mean age 27.4 years for male and 26.8 years for female migrants). Most refugees came from the Eastern Mediterranean region (83.4%), followed by immigrants from Eastern Europe (7.4%), Africa (4.6%), or other regions (4.5%). The vast majority of migrants were protected against the three VPD: overall IgG seropositivity was 88.5% for measles, 77.9% for rubella and 95.9% for varicella. However, seroprevalences showed age- and origin-dependent differences. Varicella immunity, for example, was lowest in the youngest age group of both genders (10.1% of male/4.5% of female seronegative refugees <18 years vs. 100% seropositivity in men and women >49 years of age), and Sudanese migrants displayed particularly low rates of protection against varicella. CONCLUSION: In accordance with previous studies, our analyses show an overall satisfactory seropositivity against measles, rubella, and varicella in refugees entering Europe during the current exodus. However, this rate is not sufficient for preventing transmission. For example, the rate of 12.9–17.9% female refugees at reproductive age unprotected against measles and the low protection levels against varicella in minors observed in our cohort emphasizes the need for stringent vaccination strategies in refugees coming to Europe during the current crisis. Springer Healthcare 2017-09-05 2017-12 /pmc/articles/PMC5700889/ /pubmed/28875465 http://dx.doi.org/10.1007/s40121-017-0169-7 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Jablonka, Alexandra
Happle, Christine
Wetzke, Martin
Dopfer, Christian
Merkesdal, Sonja
Schmidt, Reinhold E.
Behrens, Georg M. N.
Solbach, Philipp
Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
title Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
title_full Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
title_fullStr Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
title_full_unstemmed Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
title_short Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
title_sort measles, rubella and varicella igg seroprevalence in a large refugee cohort in germany in 2015: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700889/
https://www.ncbi.nlm.nih.gov/pubmed/28875465
http://dx.doi.org/10.1007/s40121-017-0169-7
work_keys_str_mv AT jablonkaalexandra measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT happlechristine measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT wetzkemartin measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT dopferchristian measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT merkesdalsonja measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT schmidtreinholde measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT behrensgeorgmn measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy
AT solbachphilipp measlesrubellaandvaricellaiggseroprevalenceinalargerefugeecohortingermanyin2015acrosssectionalstudy